Better Healthcare ETF: Vanguard's Broad VHT vs. the iShares Biotechnology-Focused IBB
2026-10-05 05:04
•Robert Izquierdo •The Motley Fool
•••• ••••• Axe Cap view
Healthcare ETFs: Stability vs. Biotech Growth
Comparing Vanguard's broad healthcare exposure to iShares' biotech-focused volatility.
South African investors eyeing healthcare can learn from Vanguard's Health Care ETF (VHT) and iShares Biotechnology ETF (IBB). VHT offers a diversified basket across the healthcare sector, trading at a low cost and paying a modest dividend. Its steady profile suits those who prefer less volatility, which fits well with SA’s risk-averse pockets, especially during rand fluctuations. In contrast, IBB’s biotech focus delivers exciting returns but with dramatic ups and downs—a tough ride if the rand weakens or local risk appetite tightens. Considering local stocks, SASOL’s health exposure is limited, but global healthcare leaders in VHT provide indirect opportunities. If you want growth, IBB is tempting but lean into it only if you can stomach volatility and currency swings. A potential setback for VHT buyers is that broad diversification might dull gains when biotech innovation surges, which could benefit IBB. this is just our opinion and not financial advice
Buy VHT for steady sector exposure and income, hold cautiously on IBB only as a small high-risk kicker. Avoid overcommitting to IBB given rand and biotech volatility.
- VHT
- IBB
- USD/ZAR
- rand depreciation raising offshore investment costs
- biotech sector volatility hitting IBB returns
6/10
The article compares two healthcare ETFs: Vanguard Health Care ETF (VHT) offers broad sector exposure with a low 0.09% expense ratio and 1.4% dividend yield, while iShares Biotechnology ETF (IBB) focuses on biotech with higher growth potential (49.8% 1-year return) but greater volatility and a 39.8% maximum drawdown. VHT is recommended for conservative investors seeking stability, while IBB suits high-risk growth investors.
Our take is based on reporting first published by The Motley Fool.
More stories like this
- Peter Thiel Was an Early Outside Investor in Facebook and Co-Founded Both PayPal and Palantir Before Building a Hedge Fund Now Concentrated in Power and Energy Stocks. Here's What That Track Record Says About Following His Contrarian Bets.
- How HPE Stock Gained 22.3% in September
- Tesla Is on Pace for Its First Annual Delivery Increase Since 2023. Is the Stock a Buy?